High prevalence of hypertension among Iranian children and adolescents: a systematic review and meta-analysis.

Maryam Akbari, Mahmood Moosazadeh, Sulmaz Ghahramani, Reza Tabrizi, Fariba Kolahdooz, Zatollah Asemi, Kamran B Lankarani

Journal: Journal of hypertension 2017;35(6):1155-1163

PMID: 28151773

Abstract

BACKGROUND

High blood pressure in children is a public health problem and the most important risk factor for cardiovascular disease at an older age. Several preliminary studies have been published regarding the prevalence of high blood pressure in which there was significant disparity.

OBJECTIVE

This study aimed to estimate the prevalence of hypertension in Iranian children using the meta-analysis approach.

METHODS

A systematic search of national and international databases was conducted through September 30, 2015, for population studies providing estimates on the prevalence of hypertension in Iranian children and adolescents. From the extracted prevalence rates, the heterogenic index of the studies was determined using Cochran's (Q) and Chi-squared (I2) tests, and on the basis of the heterogenetic results, a fixed or random effects model was employed to estimate the pooled prevalence rate of hypertension. Meta-regression was performed to determine those factors suspected of generating heterogeneity.

RESULTS

Of 2360 articles initially identified, 17 were considered eligible. The meta-analyses included 79 231 children and adolescents aged between 3 and 18 years. The pooled prevalence of hypertension among children and adolescents was estimated to be 8.9% [95% confidence interval (95% CI): 7.5-10.3] in overall, 10.3% (95% CI: 7.5-12.6) in males and 9.1% (95% CI: 7.4-10.7) in females. The prevalence rates of high DBP and SBP were estimated at 6.6% (95% CI: 3.9-9.2) and 6.9% (95% CI: 5.6-8.2), respectively.

CONCLUSION

There is a high prevalence of hypertension among Iranian children and adolescents. Although it is slightly higher among boys than girls, the difference was not statistically significant.

Address: aHealth Policy Research Center, Shiraz University of Medical Sciences, Shiraz bHealth Sciences Research Center, Faculty of Health, Mazandaran University of Medical Sciences, Sari cHealth Policy Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran dIndigenous and Global Health Research, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada eResearch Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan fHealth Policy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.